Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Nerinetide in Acute Ischemic Stroke (ESCAPE-NEXT)
NCT04462536Phase 3Completed
- Sponsor
- NoNO Inc.
- Start
- Dec 2020
- Primary completion
- Aug 2023
- Modality
- Peptides, Recombinant Proteins and Enzymes
- Countries
- 9
01
Overview
A Phase 3 trial of nerinetide in acute ischemic stroke (AIS), sponsored by NoNO Inc.. Started Dec 2020; status: completed.
02
Drugs
nerinetide
03
Conditions
acute ischemic stroke (AIS)
Beyond the preview
Go deeper on NCT04462536.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT04462536.